Tag Archive for: lung cancer

Sotorasib approved as the first targeted therapy for Lung Cancer

Sotorasib approved as the first targeted therapy for KRAS-Mutant Lung Cancer

Lung cancer is one of the leading cancers in Hong Kong, accounting for 26.4% of cancer mortality in 2018. Approximately 80% of the lung cancers are non-small cell lung cancer (NSCLC).

Amivantamab in combination with Lazertinib showed efficacy in NSCLC

Amivantamab in combination with Lazertinib showed efficacy in NSCLC

Non-small cell lung cancer (NSCLC) accounts for 80-85% of all lung cancer. The most frequent genetic mutation harboured in lung adenocarcinomas occurs in the epidermal growth factor receptor (EGFR), accounting for 40-55% in Asian patients.

Lung Cancer Update April 2021

Lung Cancer Update April 2021

With the World Conference on Lung Cancer (WCLC) 2020 completed last January, several new and clinical relevant phase 2 and phase 3 studies on Lung Cancer have been published. We summarised some key data for you.